Espranor (buprenorphine oral lyophilisate)
/ Ethypharm
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
March 09, 2023
EXPO: Extended-release Pharmacotherapy for Opioid Use Disorder
(clinicaltrials.gov)
- P3 | N=342 | Completed | Sponsor: King's College London | Active, not recruiting ➔ Completed | Trial completion date: Dec 2022 ➔ Mar 2023
Trial completion • Trial completion date • Substance Abuse
February 22, 2022
EXPO: Extended-release Pharmacotherapy for Opioid Use Disorder
(clinicaltrials.gov)
- P3 | N=342 | Active, not recruiting | Sponsor: King's College London | Recruiting ➔ Active, not recruiting | N=604 ➔ 342
Enrollment change • Enrollment closed • Substance Abuse
December 20, 2021
EXPO: Extended-release Pharmacotherapy for Opioid Use Disorder
(clinicaltrials.gov)
- P3; N=604; Recruiting; Sponsor: King's College London
Clinical • New P3 trial • Substance Abuse
1 to 3
Of
3
Go to page
1